1172852

Repro Lab, Inc. — FEI 3000974212

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
New York, NY (United States)

Citations

IDCFRDescription
1224121 CFR 1271.55(b)(4)Reasons for ineligibility on summary
1225521 CFR 1271.60(c)Shipped but not kept in quarantine
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence